Navigation Links
Corporate Venturing and Early-Stage Financing in the Spotlight at BioTrinity
Date:4/25/2012

rs, said: "There is no doubt that early-stage financing has been a challenge for companies, and for investors, in the sector in recent years and one without a simple, easy fix. What the panels at BioTrinity offer is the opportunity for companies to fully understand the current thinking of many of the leading venture capitalists operating in this space and so to best position themselves as an investment proposition."

The crucial question of whether there will be more or less early stage investment in 2012 is the subject of a second panel bringing together Sofinnova Partners, Apposite Capital, SV Life Sciences, Forbion Capital Partners, and Index Ventures.

Andy Smith Director of Investor and Public Relations of OBN, said: "Access to finance is one of the most pressing priorities for the majority of biotechnology companies and this year's BioTrinity provides vital insight into current trends and thinking of the investors they need to attract. The recent announcements on funding for life science R&D in the UK represent a positive change in sentiment to the sector and companies active at the earliest stage."

Other panels on day one at BioTrinity focused on trends in pharma M&A, and value-based pricing, with a high profile panel including Sir Andrew Dillon, CEO of NICE. Day two panels will cover trends in pharma licensing, ways of balancing revenue generation with R&D and spin outs.

About OBN

OBN is a not-for-profit business network which provides comprehensive support for its member biotech and medtech companies in the Oxford and South-East England biocluster and the rest of the UK. Our activities can be summarised as networking, partnering, group purchasing, and fundraising advice. Through its delivery of Europe's fastest growing biopartnering and investment conference, BioTrinity, OBN generates more R&D-company-to-investor interactions than anyone else in Europe. OBN is sponsored by Shire, as Corporate Patro
'/>"/>

SOURCE OBN
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Mars, Incorporated Answers Question: How Does Feeding People and Pets Nurture Science and Discovery? At TEDMED 2012
2. Health Diagnostic Laboratory Names Scott Blackwell Vice President of Corporate Culture
3. Kimberly-Clarks Bob Stargel Named One of Savoy Magazines Top 100 Most Influential Blacks in Corporate America
4. City of Mason and Top Gun Sales Performance Announce $4 Million Investment In New Corporate Headquarters
5. ViroPharma Incorporated Reports Fourth Quarter and Full Year 2011 Financial Results
6. SPO Updates Shareholders on 2012 Corporate Strategy
7. Insmed Incorporated Provides Corporate Update
8. Tengion Announces Relocation of Corporate Headquarters to Current Facility in Winston-Salem, North Carolina
9. WaferGen to Present Corporate Overview at 5th Annual OneMedForum San Francisco 2012
10. Inspiration Biopharmaceuticals Moves Corporate Headquarters to Cambridge, Massachusetts
11. WaferGen to Present Corporate Overview at Oppenheimer Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/16/2015)... Switzerland , April 16, 2015 /PRNewswire/ ... Debiopharm Group ™ , a Swiss-based global biopharmaceutical ... medical needs as well as companion diagnostics, ... investigational compounds Debio 1143 (SMAC mimetic) and Debio 1347/CH5183284 ... the 2015 Annual meeting of the American Association for Cancer Research ...
(Date:4/16/2015)... Madison, NJ (PRWEB) April 16, 2015 ... recruited Dr. Joseph V. Gulfo to become the ... and Entrepreneurship. Simultaneously, FDU announced the kick-off of ... new program spearheaded by Dr. Gulfo, under the ... Silberman College of Business) and in collaboration with ...
(Date:4/16/2015)... (PRWEB) April 16, 2015 Dana-Farber ... Cancer Science and Resolution Bioscience, Inc. today announced ... co-develop a novel, blood-based, clinic ready, Next Generation ... (NSCLC). The collaboration is the first to demonstrate ... and ROS1 fusions in blinded plasma samples and ...
(Date:4/16/2015)... CCI Global Channel Management, the world’s leading provider ... for major tech and telecom vendors, has released the ... vendor programs in software, hardware, and telecommunications industries. , ... top IT vendors in each segment focus their channel ... Assessment of the state of channel marketing ...
Breaking Biology Technology:Debiopharm International SA Announces Results of 2 Key Oncology Programs at 2015 AACR Conference 2Debiopharm International SA Announces Results of 2 Key Oncology Programs at 2015 AACR Conference 3Dr. Joseph V. Gulfo Named Executive Director of Fairleigh Dickinson University’s Rothman Institute to Spearhead New Initiative for Patient-Centered Innovation (iPCI) 2Dr. Joseph V. Gulfo Named Executive Director of Fairleigh Dickinson University’s Rothman Institute to Spearhead New Initiative for Patient-Centered Innovation (iPCI) 3Resolution Bioscience announces successful collaboration on a novel, non-invasive, targeted NGS test for lung cancer 2Resolution Bioscience announces successful collaboration on a novel, non-invasive, targeted NGS test for lung cancer 3CCI’s Channel Program Study Reveals 40% of IT Vendor Channel Staff Lack Adequate Access to Program and Partner Data 2CCI’s Channel Program Study Reveals 40% of IT Vendor Channel Staff Lack Adequate Access to Program and Partner Data 3
... Feb. 16, 2011 Pneumococcus ( Streptococcus pneumoniae ... of mortality in young children worldwide. While successful ... only work against specific pneumococcal strains, with the ... emerge. Through a novel discovery approach, researchers at ...
... Feb. 16, 2011 Chimerix, Inc., a pharmaceutical company ... has been awarded a contract by the Biomedical Advanced ... of Chimerix,s broad spectrum antiviral drug candidate, CMX001, as ... release. CMX001 is a potential dual-use ...
... DIEGO, Feb. 16, 2011 Optimer Pharmaceuticals, Inc. (Nasdaq: ... a public offering of 6,900,000 shares of its common ... exercise of an overallotment option previously granted to the ... price of $11.25 per share, resulting in aggregate gross ...
Cached Biology Technology:New Pneumococcal Vaccine Approach Successful in Early Tests 2New Pneumococcal Vaccine Approach Successful in Early Tests 3New Pneumococcal Vaccine Approach Successful in Early Tests 4Chimerix Awarded BARDA Contract for Advanced Development of Broad Spectrum Antiviral CMX001 as Medical Countermeasure Against Smallpox 2Chimerix Awarded BARDA Contract for Advanced Development of Broad Spectrum Antiviral CMX001 as Medical Countermeasure Against Smallpox 3Chimerix Awarded BARDA Contract for Advanced Development of Broad Spectrum Antiviral CMX001 as Medical Countermeasure Against Smallpox 4Optimer Pharmaceuticals, Inc. Announces Exercise in Full of Underwriters' Option to Purchase Additional Shares and Closing of Public Offering of Common Stock 2Optimer Pharmaceuticals, Inc. Announces Exercise in Full of Underwriters' Option to Purchase Additional Shares and Closing of Public Offering of Common Stock 3
(Date:4/1/2015)...   Medisafe ™, the leading global medication management ... and Android smartphones and tablets, announces ... platform to allow patients to track and correlate their ... patients will be able to visualize in real-time how ... such as glucose levels and blood pressure. ...
(Date:3/30/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/lc9bnl/global_gesture ) has ... Market in Automotive Sector 2014-2018" report to their ... Recognition market in Automotive Sector to grow at a ... Gesture recognition is the ability of a device to ... Gesture recognition technology can be 2D-based or 3D-based. It ...
(Date:3/24/2015)... ( http://www.researchandmarkets.com/research/kvdtcw/face_and_voice ) has announced the addition of the ... report to their offering. This report analyzes the worldwide ... following Segments: Face Biometrics, and Voice Biometrics. The report provides separate ... Japan , Europe , ... Africa , and Latin America . ...
Breaking Biology News(10 mins):Medisafe Announces Launch of Biometric Integration, Enabling Patients to Stay Adherent to Their Meds and See Tangible Health Results 2Global Gesture Recognition Market in Automotive Sector Report 2015 - Growing Number of Partnerships 2Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 2Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 3Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 4Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 5Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 6
... a serious influenza outbreak will do little to hold back ... a study conducted at the UK Health Protection Agency and ... new type of influeza virus appears that causes an illness ... flu. This happened, for example, in 1918, when a flu ...
... For the first time, scientists have defined the collective genome ... microbes, representing more than 1,000 species, make up a motley ... eat, including some vitamins, sugars, and fiber. , In ... Science , scientists at The Institute for Genomic Research (TIGR) ...
... $21 billion for HIV/AIDS research, treatment, prevention, and related ... published in the July 1 issue of The Journal ... is--and more so than previously thought. , The study, ... MD, MSc and colleagues at Massachusetts General Hospital and ...
Cached Biology News:Air travel and pandemic flu 2Gut reaction: Researchers define the colon's genome 2Gut reaction: Researchers define the colon's genome 3New study calculates millions of years saved in lives of AIDS patients 2
... is an anchorage-independent growth assay in soft ... assay for detecting malignant transformation of cells. ... carcinogens or carcinogen inhibitors) are cultured with ... 21-28 days. Following this incubation period, ...
... Kit uses a simplified procedure and streamlines ... The kit is based on the three ... and sodium bisulfite where cytosine is converted ... innovative in-column desulphonation reaction eliminates several precipitation ...
... The carbohydrate analysis standard is a ... a sugar alcohol; molecular weights range ... is provided for use with the ... analysis kit for column testing or ...
... X-Ray System from KUBTEC is a dual capability ... three dimensional representation of the specimen under test. ... specimen X-ray images, the micro focus source also ... detail in standard 2D images. The 50 mm ...
Biology Products: